A prospective audit of one hundred and forty-seven (147) Acute Pain Service (APS) patients, who received postoperative patient-controlled epidural analgesia (PCEA) using pethidine 4 mg/ml or ropivacaine 0.2% with fentanyl 2 µg/ml in general surgical or orthopaedic wards over a twelve-month period, is presented. Data were collected from APS observation charts over a 48-hour period postoperatively. We found no significant difference in postoperative analgesia or side-effects between pethidine and ropivacaine with fentanyl in orthopaedic or general surgical patients.
Patient-controlled epidural analgesia (PCEA) may be an important advance as a method of drug delivery for postoperative analgesia managed by an Acute Pain Service (APS). A unique feature of selfadministration in PCEA is that it allows the patient to balance analgesia against side-effects. PCEA can provide patients with better analgesia 1 , satisfaction 2 and safety [3] [4] . The analgesic and side-effect profile of epidural analgesia may vary according to which drugs are used 5 . PCEA with pethidine may be preferable to other epidural opioids because pethidine has intrinsic local anaesthetic activity and intermediate lipid solubility 6 . Epidural analgesia using local anaesthetic combined with opioid may show synergism 7 and provide superior analgesia during activity 8 compared with systemic opioids. This prospective audit investigated the effectiveness of analgesia and side-effects of PCEA pethidine and PCEA ropivacaine with fentanyl in orthopaedic or general surgical patients in the first 48 hours postoperatively.
MATERIALS AND METHODS
This prospective audit was conducted as part of an ongoing quality assurance program in postoperative PCEA, managed by our APS.
We excluded postoperative intensive care unit (ICU), obstetric, paediatric and chronic pain patients. Fourteen patients on epidural infusions were excluded because they were cared for in ICU during the first 48 postoperative hours. Obstetric patients were excluded because they received a single bolus of epidural or intrathecal morphine. Both postoperative paediatric and chronic pain patients were excluded because they represent a special subgroup of pain patients.
Data were prospectively collected from 147 APS patients on PCEA in general surgical or orthopaedic wards over a twelve-month period from January to December 2001. All patients received PCEA with pethidine 4 mg/ml (bolus 4 ml, lockout 15 minutes, maximum 16 ml/h) or 0.2% ropivacaine with fentanyl 2 µg/ml (bolus 3-4 ml, lockout 10 to 15 minutes, maximum 12 to 20 ml/h).
We used an 18-gauge Tuohy needle to insert 22-gauge catheters into the epidural space. The epidural catheters were inserted in the operating theatre by the attending specialist anaesthetist or anaesthetic registrar, prior to the start of surgery. The anaesthetist decided on PCEA with pethidine or with ropivacaine with fentanyl.
All catheters were fixed to the skin using a combination of Opsite Spray (Smith and Nephew, N.S.W., Australia) and transparent occlusive dressings by Tegaderm (3M, St Paul, MN, U.S.A.). Intraoperatively, epidural analgesia was maintained by continuous infusion or intermittent bolus technique. In the post-anaesthesia care unit, PCEA was initiated and the patient was monitored for one to two hours before discharge to either the orthopaedic or general surgical wards.
In the ward, patients received epidural pethidine from a 60 ml disposable syringe via a mechanical patient-controlled epidural injector (Go Medical Ltd, Western Australia). Ropivacaine with fentanyl was infused via an electronic ambulatory infusion pump, either from a 100 ml cassette (Graseby 9300, SIMS Graseby Ltd, U.K.) or a 250 ml reservoir bag (CADD-Legacy 6300, SIMS Deltec Ltd, U.S.A.).
Patient demographic data (age, sex, weight and the type of surgery) were recorded on the APS observation chart. In the ward, data were entered by nursing staff every hour for the first 12 hours, but thereafter this could be extended to every two hours depending on the patient's condition, as decided by the nursing staff and APS team. During the night, if the patient was stable, data were not collected during sleep.
The following definitions and tools were used for data collection: 1. Global pain score (verbal numerical rating scale of 0-10 (VNRS 0-10); 0=no pain, 10=maximum pain or the most pain that you had ever had). 2. Blood pressure (BP) measured by automatic noninvasive sphygmomanometer. Hypotension was a systolic BP of <90 mmHg or >30% below baseline for at least 20 minutes. 3. Respiratory rate (RR). Respiratory depression was defined as a RR <8 breaths/minute (bpm). 4. Pulse oximetry (SpO 2 ): oxygen desaturation was a SpO 2 <90%. 5. Sedation score 0-2: 0=awake/alert, 1=drowsy but rousable, 2=unrousable. 6. Nausea and vomiting score 0-4: 0=no nausea or vomiting, 1=nausea, 2=mild vomiting, 3= moderate vomiting, 4=uncontrolled vomiting requiring treatment. 7. Weakness of lower limbs assessed by modified Bromage score 0-4: 0=no weakness/movement of hips, 1=movement limited to knees, 2=movement limited to ankles, 3=no movement on lower limbs, 4=requiring follow-up by APS. 8. Pruritus score 0-3: 0=no pruritus, 1=mild pruritus, 2=moderate pruritus, 3=uncontrolled pruritus requiring treatment. 9. Urinary retention score 0-2: 0=urinary catheterization not required, 1=catheterization for surgical reason, 2=catheterization for urinary retention. Data analysis included subgroup analysis according to: Data were stored in Excel Office 2000 and analysed by SPSS10.0 software in Windows 2000. We used the independent Student's t-test to analyse univariate parametric data (VNRS, BP, RR, SpO 2 , volume of solution consumed) and the Mann-Whitney U-test to analyse ordinal data (sedation, nausea/vomiting, weakness/numbness, pruritus, urine retention) for the two methods of PCEA (pethidine or ropivacaine with fentanyl) and for type of surgery (UA, LA or LL). The Chi-squared test was used to analyse categorical patient demographic data. A P value of <0.05 was considered significant.
RESULTS

Demographics
During the twelve-month period a total of 147 patients received PCEA with pethidine 4 mg/ml (n=84) or ropivacaine 0.2% with fentanyl 2 µg/ml (n=63). The incidence of failed epidural analgesia was small (<5%) and did not differ between the mechanical or electronic devices. Patient age ranged from 23 to 86 years (mean 66.4 years for pethidine PCEA and 66.1 years for ropivacaine and fentanyl PCEA). The pethidine group had a higher male to female ratio and patient body weight. There was more lower limb surgery than abdominal surgery performed in both groups. After upper abdominal surgery, ropivacaine with fentanyl was used more frequently than pethidine. Patient demographic data are shown in Table 1 .
The types of surgery categorized into upper abdominal (UA), lower abdominal (LA) or lower limb (LL) surgery are described in Table 2 . A total of 105 lumbar epidurals and 42 thoracic epidurals were inserted. All patients having lower limb surgery had lumbar epidural catheters. Those having upper abdominal surgery had either thoracic (T9/10, T10/11) or upper lumbar (L1/2) epidural analgesia.
Analgesia
Global pain scores at 0-2 h, 2-6 h, 6-12 h, 12-24 h and 24-48 h were compared by type of surgery (Table 3 ). There was no significant difference between PCEA pethidine and PCEA ropivacaine with fentanyl.
Side-Effects
The incidence of side-effects for PCEA pethidine and PCEA ropivacaine with fentanyl groups is shown in Table 4 , with mean values shown in Table 5 .
Three patients had a sedation score of 1 (drowsy but rousable); all had PCEA pethidine and they had undergone total gastrectomy, subtotal gastrectomy and low anterior resection respectively. No patient Values are mean (SD). VNRS=0-10 verbal numerical rating score. had a sedation score of 2 (unrousable). No respiratory depression or oxygen desaturation was noted.
PCEA Volume of Solution
The volume of epidural solution administered in the first and second 24 hour periods was audited to calculate the mean dose per hour (mg/h). The volume of PCEA pethidine used was significantly lower for both the 0-24 h and 24-48 h periods ( Table 6 ).
The mean dose of the pethidine administered in the first and second 24 hour period was 9.3 mg/h and 7.7 mg/h respectively.
Subgroup Analysis for Type of Surgery
When the 48 hour postoperative period was analysed according to the type of surgery, there was no significant difference between PCEA pethidine and PCEA ropivacaine with fentanyl for the global pain score. However, the volume of PCEA pethidine administered was significantly lower for patients having lower limb (LL) surgery. There was no significant difference between groups for pain scores or volume of solution after upper and lower abdominal surgery ( Table 7) .
The mean dose of PCEA pethidine used during the first and second 24 hour postoperative periods after lower limb surgery was 8.3 mg/h and 7.6 mg/h respectively. This was lower than the dose used after upper abdominal (12.6 mg/h and 11.5 mg/h) or lower abdominal (10.8 mg/h and 7.1 mg/h) surgery.
DISCUSSION
In 1988, Sjostrom and colleagues 9 first studied PCEA using pethidine and morphine after laparotomy. Since then, epidural pethidine has gained popularity, particularly in obstetrics. In his review, Ngan Kee suggested a potential advantage of epidural pethidine over other opioids was its intermediate lipid solubility 6 . Pethidine has an octanol:water partition coefficient of 38.8, compared with 1.42 for morphine and 813 for fentanyl. Its analgesic effect is mainly spinal rather than supraspinal 1 . Pethidine has local anaesthetic effects both in vitro 10 features have made pethidine an attractive drug for PCEA. Clinically, PCEA with pethidine was better than PCEA with fentanyl after caesarean section 12, 13 . After thoracotomy, PCEA with 0.1% pethidine alone was associated with similar efficacy and fewer motor, sensory or autonomic side-effects than 0.1% pethidine with bupivacaine 14 . After abdominal surgery, it is equianalgesic with bupivacaine and fentanyl and with bupivacaine and diamorphine 15 . When compared with patient-controlled intravenous pethidine, PCEA with pethidine achieved superior pain control at lower plasma pethidine concentrations after upper abdominal 16 or abdominal aortic surgery 17 .
This was an audit, so our patients were not randomized to the PCEA group. Our results may have been confounded by differences in drug delivery devices (mechanical versus electronic), by unblinded observers, the greater male/female ratio in the PCEA pethidine group and the more frequent use of PCEA ropivacaine with fentanyl for upper abdominal surgery. We found no significant difference in global pain scores or side-effects between pethidine 4 mg/ml and ropivacaine 0.2% with fentanyl 2 µg/ml in the first 48 hour postoperative period after orthopaedic surgery. We also confirmed the safety of both the techniques, because the incidence of hypotension, respiratory depression and oxygen desaturation was low. The PCEA pethidine technique had the advantage of simplicity (for preparation or refilling of the device) and the absence of the excessive motor, sensory or autonomic blockade, which is of particular relevance for lower limb surgery.
Our audit also confirmed the effectiveness of both PCEA techniques for upper and lower abdominal surgery. However, most of our anesthetists prefer to use ropivacaine with fentanyl in upper abdominal surgery, reflecting knowledge that multimodal analgesia using local anaesthetic with opioid can provide superior analgesia 8 , facilitate chest physiotherapy and reduce the incidence of ileus after abdominal surgery 5 . For each type of surgery, the audit did not identify any significant difference between PCEA pethidine and PCEA ropivacaine with fentanyl in terms of quality of analgesia or side-effect profile. Explanations may be the same vigilance of care provided by the staff of APS and the general wards, and the consistent approach to PCEA despite use of different devices. We believe the availability of an APS improved patients' confidence and competence, and gave patients a realistic expectation of pain or sideeffects. Attempts to balance analgesic and other effects may depend on patients' functional or mental competence in use of the device and individual preference.
We noted the use of larger epidural volumes after upper or lower abdominal surgery compared with lower limb surgery. The only significant difference found between PCEA with pethidine and PCEA with ropivacaine and fentanyl was the use of lower volumes of solution after lower limb surgery in the pethidine group. This suggests that lumbar and thoracic epidural pethidine may behave differently or that the ipsilateral nature of lower limb surgery leads to different requirements to the bilateral stimulation of midline upper or lower abdominal incisions and surgery. To our knowledge, the lumbar and thoracic routes have not been compared for epidural pethidine. However, rapid cephalic spread of lumbar epidural pethidine 18 may lead to adequate analgesia even for thoracotomy 19 .
Our calculated mean consumption of pethidine after upper abdominal surgery was higher than that reported in previous studies of upper abdominal surgery (10.6 mg/h) 16 and thoracotomy (5-6 mg/h) 14 . Our PCEA pethidine bolus was 16 mg (concentration 4 mg/ml, bolus 4 ml), which was more than the 10 mg (concentration 5 mg/ml, bolus 2 ml) used in a study involving abdominal surgery 16 or the 5 mg (concentration 1 mg/ml, bolus 5 ml) used in a thoracotomy study 14 . A single bolus of 50 mg or 75 mg of epidural pethidine may cause respiratory depression within five minutes to five hours of injection 6 . Irrespective of the size of the bolus dose, close postoperative monitoring of the level of sedation and respiratory function are mandatory,
The results of this audit were that PCEA with pethidine 4 mg/ml and with ropivacaine 0.2% with fentanyl 2 µg/ml produced similar analgesia and side-effects in postoperative general surgical and orthopaedic patients.
